Semaglutide, a once‐weekly human GLP‐1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|55|5|497-504

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.5, 2015-05, pp. : 497-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dulaglutide: a once‐weekly GLP‐1 for type 2 diabetes

By  

PRESCRIBER, Vol. 26, Iss. 19, 2015-10 ,pp. : 28-30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 378-388

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liraglutide: a human GLP-1 analog for Type 2 diabetes

By Vilsbøøll Tina  

Therapy, Vol. 6, Iss. 2, 2009-03 ,pp. : 199-207

Future Medicine

Access to resources Recommend Favorite

Randomized, active-controlled study of once-weekly alendronate 280 mg high dose oral buffered solution for treatment of Paget’s disease

By Hooper M.   Faustino A.   Reid I.   Hosking D.   Gilchrist N.   Selby P.   Wu M.   Salzmann G.   West J.   Leung A.  

Osteoporosis International, Vol. 20, Iss. 1, 2009-01 ,pp. : 141-150

Springer Publishing Company

Access to resources Recommend Favorite

Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis

By Sebba Anthony I.   Bonnick Sydney Lou   Kagan Risa   Thompson Desmond E.   Skalky Carol S.   Chen Erluo   de Papp Anne E.    

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 2031-2041

Informa Healthcare

Access to resources Recommend Favorite